{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:18:20Z","timestamp":1759058300992},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T00:00:00Z","timestamp":1230854400000},"content-version":"vor","delay-in-days":701,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives\/Hypothesis:<\/jats:bold> Our aim was to evaluate the combined effect of 5\u2010fluorouracil (5\u2010FU) and myringotomy for the treatment of otitis media with effusion (OME). OME is usually treated with medication, myringotomy, or insertion of a ventilation tube (VT). Except for VT insertion, however, treatment effects are short\u2010lived. VT insertion has numerous sequelae: increased susceptibility to infection, large perforation of the tympanic membrane, cholesteatoma, and eventual hearing deterioration. We estimated the depressant action of 5\u2010FU on normal cell proliferation in vitro. In addition, clinically, we assessed whether 5\u2010FU has the potential to prolong the effect of myringotomy.<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> An in vitro study and a clinical study were conducted.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> In study I, fibroblasts harvested from the peritoneum of three green fluorescent protein transgenic mice were cultured with different doses of 5\u2010FU. After 2 weeks, their proliferation rates were compared. In study II, patients (54 males, 47 females) were selected randomly from a group of patients with intractable OME. Myringotomy with or without a single dose of 5\u2010FU ointment (approximately 0.10\u20130.30 mg) was performed in group I (n = 64) and group II (n = 37), respectively. The natural closure rates of the tympanic membrane were assessed in both groups.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In vitro, 5\u2010FU inhibited the growth of fibroblasts in a dose\u2010dependent manner. The average time to tympanic membrane closure was 20.5 days in group I and 8.1 days in group II. No adverse events were observed in either group.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Topical application of 5\u2010FU ointment is useful in prolonging the effect of myringotomy. 5\u2010FU ointment therapy is easy, safe, and cost\u2010effective and may be of wide application.<\/jats:p>","DOI":"10.1097\/01.mlg.0000248231.62834.e3","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T06:39:31Z","timestamp":1170484771000},"page":"215-219","source":"Crossref","is-referenced-by-count":6,"title":["5\u2010Fluorouracil Ointment for the Treatment of Otitis Media With Effusion"],"prefix":"10.1002","volume":"117","author":[{"given":"Shin\u2010ichi","family":"Kanemaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhmar","family":"Magrfov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Omori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2310\/7070.2005.34503"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348940411300604"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1999.0684"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(00)00347-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200203000-00007"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000169797.60824.3b"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000169760.70302.f1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199708000-00020"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016489950181972"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000154731.08410.b8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199812000-00014"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2002.00599.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200204000-00013"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000147944.20676.17"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.3.707"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.PRS.0000169701.16509.D6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.5.581"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0021-9258(19)76419-9","article-title":"Studies on fluorinate pyrimidines. XIII. Inhibition of thymidylate synthetase.","volume":"236","author":"Hartman KU","year":"1961","journal-title":"J Biol Chem"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)31781-6"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090020117035"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.01.003"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020613600826"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.mlg.0000248231.62834.e3","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.mlg.0000248231.62834.e3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T04:19:30Z","timestamp":1695961170000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.mlg.0000248231.62834.e3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1097\/01.mlg.0000248231.62834.e3"],"URL":"https:\/\/doi.org\/10.1097\/01.mlg.0000248231.62834.e3","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}